Search Results

Use of HardyDisk AST Ceftazidime/Avibactam, (30/20ug) - CZA50, for in vitro agar diffusion susceptibility testing is indicated when there is need to determine the susceptibility of bacteria to Ceftazidime/Avibactam.

The concentration of Ceftazidime/Avibactam, (30/20ug) - CZA50, has been shown to be active against susceptible isolates of the following microorganisms with in vitro use: Morganii, Providencia rettgeri, and Serratia marcescens.

The concentration of Ceftazidime/Avibactam, (30/20ug) - CZA50, has been shown to be active against susceptible isolates of the following microorganisms with both in vitro and in clinical infections: Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis, Providencia stuartii, Pseudomonas aeruginosa, Citrobacter freundii, Citrobacter koseri, Proteus spp., and Enterobacter aerogenes.

Not Found

This document is a 510(k) clearance letter for an antimicrobial susceptibility test disc (Hardydisk AST Ceftazidime/Avibactam). It does not contain information about acceptance criteria or a study proving the device meets those criteria. The letter acknowledges the clearance of the device based on substantial equivalence to a predicate device, but it does not detail the specific performance metrics or studies performed.

Therefore, I cannot provide the requested information from the provided text.

Ask a specific question about this device